factual

Pharma criticism is career-suppressing in academia

Writing or even publicly endorsing criticism of a pharmaceutical product is career-damaging for academics, with colleagues admitting they agree privately but cannot even 'like' a critique on Twitter because they have company meetings about trials they want to run.

factualpending

Speaker

Vinay Prasad

Evidence Quote

“I can't even like it on Twitter because I can't even like it. I want to like it, but I can't like it.”

Source

Vinay Prasad on Pharmaceuticals, the FDA, and the Death of Duty— EconTalk
Created: 6/13/2026, 3:32:57 AM

Your notes

Loading notes...